St. Jude Children’s Research Hospital shared on LinkedIn:
“Advancing pediatric cancer care requires collaboration across disciplines, institutions and borders.
Through a partnership with Nature, St. Jude brought researchers, clinicians, policymakers and patient advocates together in Memphis for the Nature Portfolio Conference, ‘Accelerating Pediatric Cancer Innovation: From Research to Real-World Impact.’
The two-day program connected scientific advances in precision oncology, molecular diagnostics and novel therapies with broader discussions about survivorship, access to care, health systems and disparities in childhood cancer outcomes.
The conversation also extended beyond Memphis, with attendees joining from more than 30 countries and territories.
More than 250 participants joined in person, while nearly 1,000 joined virtually through a free livestream provided by St. Jude, expanding the opportunity to share knowledge with a global audience working to improve care and outcomes for children with cancer.
Carlos Rodriguez-Galindo, St. Jude Global Director and Executive Vice President, said:
‘Bringing these perspectives together helps us better understand how scientific advances can improve diagnosis, care and outcomes for children around the world, throughout treatment and survivorship.’
‘Our shared ambition is a future in which every child can benefit from that progress, wherever they live.’
Through its partnership with Nature, St. Jude helped provide a forum for the global pediatric cancer community to exchange ideas, examine challenges and consider approaches that can move the field forward.”
Read more articles about Childhood Cancer on OncoDaily.
